First US Patient Implanted in IDE Study of DuraSorb Monofilament Mesh Use in Prosthetic Breast Reconstruction

Surgical Innovation Associates (SIA) announces that the first patient has been enrolled in a pivotal trial of its flagship absorbable mesh, DuraSorb, under an investigational device exemption (IDE) from the FDA. The study will evaluate the safety and effectiveness of DuraSorb for reinforcement in prosthetic breast reconstruction.